Daxor Corp DXR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $10.65
- Day Range
- $10.60–11.19
- 52-Week Range
- $0.00–14.76
- Bid/Ask
- $10.11 / $12.24
- Shares Outstanding
- 5.84M
- Market Cap
- $61.89M
- Volume/Avg
- 1,817 / 4,798
Key Statistics
- Price/Earnings (Normalized)
- 6.46
- Price/Sales
- 5.12
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 750
- Website
- https://www.daxor.com
Valuation
|
Metric
|
DXR
|
|---|---|
Price/Earnings (Normalized) | 6.46 |
Price/Book Value | 1.17 |
Price/Sales | 5.12 |
Price/Cash Flow | 96.13 |
Price/Earnings
DXR
Financial Strength
|
Metric
|
DXR
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
DXR
|
|---|---|
Return on Assets (Normalized) | 23.21% |
Return on Equity (Normalized) | 23.45% |
Return on Invested Capital (Normalized) | — |
Return on Assets
DXR
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|KJ><GGg | LOCK|J^X | $138B | |||
| Becton Dickinson & Co
BDX
| LOCK|!bH | LOCK|Y>&$z | $43B | |||
| Alcon Inc
ALC
| LOCK|v#@Tx^ | LOCK|k>bp% | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|V&TZ>!H | LOCK|TK$V | $33B | |||
| ResMed Inc
RMD
| LOCK|$CS>C?T | LOCK|@ln< | $29B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|ys@CNM& | LOCK|Kj? | $25B | |||
| The Cooper Companies Inc
COO
| LOCK|Gt<hnt | LOCK|<!zy% | $14B | |||
| Solventum Corp
SOLV
| LOCK|rftNqVc | LOCK|^^& | $14B | |||
| Align Technology Inc
ALGN
| LOCK|Kh#&rs | LOCK|xM@b | $13B | |||
| Baxter International Inc
BAX
| LOCK|>@@ | LOCK|b%G^ | $11B |
United States